Looking for a venue in NYC to host a fireside chat for 100-200 people next week
DM me or @andruyeung if you have something that could work
Dinner / drinks on us if you help us source something 👀
🤖 Did you just read a pointed AI-generated article?
OpenAI has just exposed an account generating synthetic geopolitical commentary about Africa and laundering it in African news outlets.
🔗 Read more here: https://t.co/7y6vNLIhaM
4 days out from my life-changing surgery, @Aetna has denied the appeal for my brain surgery.
to be clear, when i signed up to aetna months ago, the coordinator had confirmed they would cover this surgery. then, a week ago, they said the surgery was too experimental/elective and denied coverage. we appealed. that appeal was just denied today.
now, my neurosurgeon is trying to do a peer-to-peer consult with someone at aetna to explain why i need it so we don’t lose the surgery date on monday morning. aetna is not being responsive.
this is sadistic and a violation of basic trust. please spread this so they can’t ignore it. they may not care if i live or die but people should know just what kind of company they’re dealing with. and please pray they are able to have a peer-to-peer consult with my neurosurgeon and have a change of heart.
@19thnews is hiring an audience growth manager! Apply today to collaborate across departments and develop and execute an audience growth strategy to reach the women and LGBTQ+ people we aim to serve. Deadline: September 9.
https://t.co/DX2aviR7Yv
AI colleagues - dig into this research paper!
The possibilities are breathtaking. We mustn’t let other AI topics consume all oxygen in room - medical innovation is a plausible superpower.
[disclaimer: @PatrickHwuMD, now CEO of Moffit, was formerly my doctor at MD Anderson]
#ScienceSaturday
❓ Can AI help us engineer better cancer therapies, one protein at a time?
➡️ A new study in Science reveals how generative AI is being used to rapidly create de novo protein minibinders to target cancer-associated peptide–MHC complexes (pMHCs), which are key triggers for T cell activation.
➡️ Using tools like RFdiffusion, AlphaFold2, and ProteinMPNN, researchers engineered minibinders that mimic T cell receptors and bind to tumor-specific pMHC targets like NY-ESO-1. When incorporated into CARs, these AI-designed molecules enabled T cells to kill #melanoma cells in lab experiments.
🌟 This approach could streamline and personalize T cell therapies, especially in cancers where conventional TCR discovery is too slow or difficult. It opens a path to designing synthetic proteins in weeks, not years, with built-in specificity and potency.
🔗 Read more in @ScienceMagazine: https://t.co/35lXkW2QWJ
@TimothyPJenkins@KrisHaurum@DTUtweet@DTUbioengineer
#CancerResearch #AI #Immunotherapy #CancerImmunotherapy
General Tony Thomas (T2 to those who know him - @TonyT2Thomas) never stops caring for men and women in uniform, and their children.
Pls support him as he rides 406 miles on his bike to raise money for the SPECIAL OPERATIONS WARRIOR FOUNDATION (SOWF).
Link below.